Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04285658 · ClinicalTrials.gov registry record
Pediatric KIDney Stone (PKIDS) Care Improvement Network
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 1,290
- Enrollment target
NCT04285658: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT04285658 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 1,290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04285658 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 1,290 participants
- Enrollment target
Study Summary
The goals of this study are to improve the ability of pediatric patients and their caregivers to select surgical treatment options for kidney stones and to enable urologists to use techniques that result in the best outcomes for these surgeries.
Primary Outcome
Presence or absence of kidney stones will be assessed via post-operative clinically-indicated renal bladder ultrasound.
Interventions
- PROCEDURE Ureteroscopy
- PROCEDURE Percutaneous Nephrolithotomy
- PROCEDURE Shock Wave Lithotripsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,290 participants |
| Start Date | 2020-04-02 |
| Est. Completion | 2024-01-31 |
What the finished NCT04285658 record still lists
NCT04285658 is an observational study that tracks outcomes without assigning an intervention. Its 1,290 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Ureteroscopy is the first listed.
NCT04285658 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04285658 about?
NCT04285658 is a clinical study titled "Pediatric KIDney Stone (PKIDS) Care Improvement Network". The goals of this study are to improve the ability of pediatric patients and their caregivers to select surgical treatment options for kidney stones and to enable urologists to use techniques that result in the best outcomes for these surgeries.
What is the current status of trial NCT04285658?
This trial is currently completed. The enrollment target is 1,290 participants. The study started on 2020-04-02. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT04285658?
The interventions under investigation include: Ureteroscopy (PROCEDURE), Percutaneous Nephrolithotomy (PROCEDURE), Shock Wave Lithotripsy (PROCEDURE).
Who is sponsoring clinical trial NCT04285658?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI